Reata Pharmaceuticals Inc

Ownership Transactions Reported by 20 Insiders

Industry
Pharmaceutical Preparations
Location
5320 Legacy Drive, Plano, TX

There are no Buy or Sell transactions made by insiders since 11/5/2023

Reata Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Samina Khan SVP, Chief Medical Officer $6.79M May 15, 2023
Elaine Castellanos VP, Chief Accounting Officer $2.5M Jun 7, 2021
William D. McClellan Jr. Director Sep 26, 2023
Michael D. Wortley Chief Legal Officer Sep 26, 2023
Jack Nielsen Director Jun 10, 2021
Shamim Ruff Director Sep 26, 2023
Manmeet Soni COO, CFO and President Sep 26, 2023
Dawn Carter Bir Chief Commercial Officer Sep 26, 2023
Andrea Loewen SVP, Global Regulatory Affairs Sep 26, 2023
Steven Ryder Director Sep 26, 2023
Rajiv Patni EVP, Chief R&D Officer Sep 26, 2023
Antal Rohit Desai Director, 10%+ Owner Sep 26, 2023
William Rose Director Sep 26, 2023
Bhaskar Anand SVP, Chief Accounting Officer Sep 26, 2023
Christy J. Oliger Director Sep 26, 2023
Martin Edwards Director Sep 26, 2023
R. Kent Jr McGaughy Director, 10%+ Owner Sep 26, 2023
James Warren Huff Chief Executive Officer, Director Sep 26, 2023
Biogen Inc. Other* Jul 28, 2023
Colin John Meyer Chief Innovation Officer Sep 26, 2023

Recent Insider Transactions by Companies or Individuals for Reata Pharmaceuticals Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.